Neuroendocrine Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-11-17
Clinical Trial Update: Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer [Phase 1, Phase 2]
A dose-escalation Phase 1 study followed by expansion Phase 2 trial of ZG006 in advanced small cell lung cancer and neuroendocrine cancer, c…